Verizon Communications Inc. officer Kyle Malady filed a Form 144 notice on October 27, 2026, proposing the sale of 1,100 shares of Verizon common stock through Fidelity Brokerage Services LLC on NYSE.

Key Highlights

  • Proposed sale: 1,100 shares of Verizon Communications Inc. common stock with an aggregate market value of $47,300.00.
  • Approximate sale date: October 27, 2026, to be executed through Fidelity Brokerage Services LLC on the NYSE.
  • Source of shares: The 1,100 shares were acquired on March 1, 2026, via restricted stock vesting from the issuer as compensation.
  • Rule 10b5-1 plan: The filing indicates a trading plan or instruction was adopted on May 18, 2026.
  • Prior sales in last 3 months: Ten separate sales of 1,100 shares each were reported between August 18, 2026, and October 20, 2026, with gross proceeds ranging from $47,223.00 to $56,309.00 per transaction.
  • Shares outstanding: Verizon reported 4,154,775,202 shares of common stock outstanding as stated in the filing.

Malady's October 27 Proposed Sale in the Context of Verizon's Officer Disclosures

According to the Form 144 filing, Kyle Malady, identified as an officer of Verizon Communications Inc. (NYSE:VZ), proposed to sell 1,100 shares of the company's common stock at an aggregate market value of $47,300.00. The proposed sale was to be carried out on approximately October 27, 2026, through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, Rhode Island. The shares were originally acquired through a restricted stock vesting event on March 1, 2026, when the issuer granted them to Malady as compensation.

The filing also discloses that Malady relied on a Rule 10b5-1 plan, with the date of plan adoption or instruction recorded as May 18, 2026. Verizon Communications Inc., headquartered at 1095 Avenue of the Americas, New York, New York, is one of the largest telecommunications companies in the United States, providing wireless and wireline communications services and products to consumers, businesses, and government entities. The filing identifies the company's SEC File Number as 001-08606 and lists total shares of common stock outstanding at 4,154,775,202.

The notice also records ten prior sales by Malady during the three months preceding this filing. Each of those transactions involved 1,100 shares of Verizon common stock, with gross proceeds per sale ranging from $47,223.00 on October 13, 2026, to $56,309.00 on September 15, 2026. The aggregate proceeds across those ten prior transactions totaled $525,382.00, as individually itemized in the filing. The notice was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Kyle Malady.

What Was Disclosed

The Form 144 notice, dated October 27, 2026, disclosed Kyle Malady's proposed sale of 1,100 Verizon common shares valued at $47,300.00, acquired through restricted stock vesting, along with ten prior sales of 1,100 shares each conducted between August 18 and October 20, 2026, under a Rule 10b5-1 plan adopted May 18, 2026.